Literature DB >> 30866714

The success of fecal microbial transplantation in Clostridium difficile infection correlates with bacteriophage relative abundance in the donor: a retrospective cohort study.

Heekuk Park1,2, Michael R Laffin3, Juan Jovel1,2, Braden Millan1,2, Jae E Hyun1,2, Naomi Hotte1,2, Dina Kao1,2, Karen L Madsen1,2.   

Abstract

Background: Fecal microbial transplantation (FMT) is used in the treatment of relapsing Clostridium difficile infection (rCDI). Failure rate for FMT is as high as 10% but the mechanisms contributing to a failed FMT are not understood. We utilized metagenomic data to identify the role of bacteria and bacteriophages on FMT success.
Results: Subjects with rCDI (n = 19) received FMT from volunteer donors (n = 7) via colonoscopy. Twelve patients fully recovered after a single FMT, while seven patients required a subsequent FMT. DNA was extracted from patient and donor stool samples for shotgun metagenomic analysis. Metagenomics libraries were analyzed focusing on bacterial taxonomy and bacteriophage sequences. Gammaproteobacteria were dominant in rCDI patients prior to FMT largely due to elevated levels of Klebsiella and Escherichia. A successful FMT led to increased levels of Clostridia and Bacteroidia and a reduction in Gammaproteobacteria. In contrast, a failed FMT led to no significant changes in bacterial composition. Bacteriophages were classified during whole metagenomic analysis of each sample and were markedly different between rCDI patients, donors, and a healthy control cohort (n = 96). Bacteriophage sequence reads were increased in CDI patients compared with donors and healthy controls. Successful FMT donors had higher bacteriophage α-diversity and lower relative abundance compared to the donors of a failed initial FMT.Conclusions: In this retrospective analysis, FMTs with increased bacteriophage α-diversity were more likely to successfully treat rCDI. In addition, the relative number of bacteriophage reads was lower in donations leading to a successful FMT. These results suggest that bacteriophage abundance may have some role in determining the relative success of FMT.

Entities:  

Keywords:  Clostridium difficile infection; FMT; bacteriophages; intestinal microbiome

Mesh:

Year:  2019        PMID: 30866714      PMCID: PMC6867182          DOI: 10.1080/19490976.2019.1586037

Source DB:  PubMed          Journal:  Gut Microbes        ISSN: 1949-0976


  45 in total

Review 1.  Fecal Microbiota Transplantation for Clostridium difficile Infection: A Systematic Review.

Authors:  Dimitri Drekonja; Jon Reich; Selome Gezahegn; Nancy Greer; Aasma Shaukat; Roderick MacDonald; Indy Rutks; Timothy J Wilt
Journal:  Ann Intern Med       Date:  2015-05-05       Impact factor: 25.391

2.  Effect of Oral Capsule- vs Colonoscopy-Delivered Fecal Microbiota Transplantation on Recurrent Clostridium difficile Infection: A Randomized Clinical Trial.

Authors:  Dina Kao; Brandi Roach; Marisela Silva; Paul Beck; Kevin Rioux; Gilaad G Kaplan; Hsiu-Ju Chang; Stephanie Coward; Karen J Goodman; Huiping Xu; Karen Madsen; Andrew Mason; Gane Ka-Shu Wong; Juan Jovel; Jordan Patterson; Thomas Louie
Journal:  JAMA       Date:  2017-11-28       Impact factor: 56.272

3.  Classification and quantification of bacteriophage taxa in human gut metagenomes.

Authors:  Alison S Waller; Takuji Yamada; David M Kristensen; Jens Roat Kultima; Shinichi Sunagawa; Eugene V Koonin; Peer Bork
Journal:  ISME J       Date:  2014-03-13       Impact factor: 10.302

4.  Fecal Microbial Transplantation in Inflammatory Bowel Disease: A Movement Too Big to Be Ignored.

Authors:  M Laffin; K L Madsen
Journal:  Clin Pharmacol Ther       Date:  2017-07-10       Impact factor: 6.875

5.  Rapid evolution of the human gut virome.

Authors:  Samuel Minot; Alexandra Bryson; Christel Chehoud; Gary D Wu; James D Lewis; Frederic D Bushman
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-08       Impact factor: 11.205

Review 6.  Fecal microbial transplantation as a therapeutic option in patients colonized with antibiotic resistant organisms.

Authors:  Michael Laffin; Braden Millan; Karen L Madsen
Journal:  Gut Microbes       Date:  2017-01-06

7.  Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea.

Authors:  Alexander Khoruts; Johan Dicksved; Janet K Jansson; Michael J Sadowsky
Journal:  J Clin Gastroenterol       Date:  2010 May-Jun       Impact factor: 3.062

8.  Species and genus level resolution analysis of gut microbiota in Clostridium difficile patients following fecal microbiota transplantation.

Authors:  Vijay Shankar; Matthew J Hamilton; Alexander Khoruts; Amanda Kilburn; Tatsuya Unno; Oleg Paliy; Michael J Sadowsky
Journal:  Microbiome       Date:  2014-04-21       Impact factor: 14.650

9.  Shiny-phyloseq: Web application for interactive microbiome analysis with provenance tracking.

Authors:  Paul J McMurdie; Susan Holmes
Journal:  Bioinformatics       Date:  2014-09-26       Impact factor: 6.937

10.  Microbiome Helper: a Custom and Streamlined Workflow for Microbiome Research.

Authors:  André M Comeau; Gavin M Douglas; Morgan G I Langille
Journal:  mSystems       Date:  2017-01-03       Impact factor: 6.496

View more
  11 in total

Review 1.  Recipient factors in faecal microbiota transplantation: one stool does not fit all.

Authors:  Camille Danne; Nathalie Rolhion; Harry Sokol
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-04-27       Impact factor: 46.802

Review 2.  Capturing the environment of the Clostridioides difficile infection cycle.

Authors:  Matthew K Schnizlein; Vincent B Young
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-04-25       Impact factor: 73.082

Review 3.  Faecal microbiota transplantation for Clostridioides difficile: mechanisms and pharmacology.

Authors:  Alexander Khoruts; Christopher Staley; Michael J Sadowsky
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-08-25       Impact factor: 46.802

4.  Faecal microbiota transplantation for recurrent Clostridioides difficile infection: An updated systematic review and meta-analysis.

Authors:  Simon Mark Dahl Baunwall; Mads Ming Lee; Marcel Kjærsgaard Eriksen; Benjamin H Mullish; Julian R Marchesi; Jens Frederik Dahlerup; Christian Lodberg Hvas
Journal:  EClinicalMedicine       Date:  2020-11-23

5.  Alterations and Prediction of Functional Profiles of Gut Microbiota After Fecal Microbiota Transplantation for Iranian Recurrent Clostridioides difficile Infection with Underlying Inflammatory Bowel Disease: A Pilot Study.

Authors:  Masoumeh Azimirad; YoungJae Jo; Min-Sueng Kim; Minsoo Jeong; Shabnam Shahrokh; Hamid Asadzadeh Aghdaei; Mohammad Reza Zali; Seungjun Lee; Abbas Yadegar; Jae-Ho Shin
Journal:  J Inflamm Res       Date:  2022-01-06

Review 6.  Roles of Gut Bacteriophages in the Pathogenesis and Treatment of Inflammatory Bowel Disease.

Authors:  Lingling Qv; Sunbing Mao; Yongjun Li; Jia Zhang; Lanjuan Li
Journal:  Front Cell Infect Microbiol       Date:  2021-11-25       Impact factor: 5.293

Review 7.  The Human Gut Phageome: Origins and Roles in the Human Gut Microbiome.

Authors:  Eleanor M Townsend; Lucy Kelly; George Muscatt; Joshua D Box; Nicole Hargraves; Daniel Lilley; Eleanor Jameson
Journal:  Front Cell Infect Microbiol       Date:  2021-06-04       Impact factor: 5.293

8.  Understanding the mechanisms of efficacy of fecal microbiota transplant in treating recurrent Clostridioides difficile infection and beyond: the contribution of gut microbial-derived metabolites.

Authors:  Laura Martinez-Gili; Julie A K McDonald; Zhigang Liu; Dina Kao; Jessica R Allegretti; Tanya M Monaghan; Grace F Barker; Jesús Miguéns Blanco; Horace R T Williams; Elaine Holmes; Mark R Thursz; Julian R Marchesi; Benjamin H Mullish
Journal:  Gut Microbes       Date:  2020-11-09

Review 9.  The Gut-Liver Axis in Cholestatic Liver Diseases.

Authors:  Andreas Blesl; Vanessa Stadlbauer
Journal:  Nutrients       Date:  2021-03-21       Impact factor: 5.717

Review 10.  Phages in the Gut Ecosystem.

Authors:  Michele Zuppi; Heather L Hendrickson; Justin M O'Sullivan; Tommi Vatanen
Journal:  Front Cell Infect Microbiol       Date:  2022-01-04       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.